Immuron Board Changes

MELBOURNE, Australia, May 31, 2024 -- Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as...

Related Keywords

United States ,Melbourne ,Victoria ,Australia ,Canada ,United Kingdom ,Australian ,American ,Roger Aston ,Jeannie Joughin ,Steven Lydeamore ,Flagellin Sears ,Paul Brennan ,Nasdaq ,Securities Exchange ,Bristol Myers Squibb ,Immuron Limited ,Immuron Platform Technology ,Non Executive Director ,Non Executive Chairman ,Australian Register ,Therapeutic Goods ,Opin Infect ,Scandinavian Journal ,Tropical Medicine ,Immune Components ,Anti Diarrheagenic Enterotoxigenic Escherichia ,Hyperimmune Bovine Colostrum ,Immuron News ,Securities Act ,Securities Exchange Act ,